Prosthetic Heart Valve Devices And Equipment Market Expansion Is Opening New Pathways For Strategic Investment
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
The prosthetic heart valve devices and equipment market is witnessing significant expansion as advancements in cardiac treatment continue to evolve. Increasing cases of valvular heart diseases and technological innovations are driving this sector’s steady growth. Let’s explore the market’s current size, growth drivers, segmentation, key innovations, competitive landscape, and regional outlook to understand the future trajectory.
Prosthetic Heart Valve Devices and Equipment Market Size and Growth Outlook
The market for prosthetic heart valve devices and equipment has shown strong growth in recent years. It is projected to rise from $6.73 billion in 2025 to $7.17 billion in 2026, representing a compound annual growth rate (CAGR) of 6.5%. Factors such as a growing elderly population, increased prevalence of valvular heart conditions, expansion of cardiac surgery programs, higher adoption of valve replacement procedures, and advancements in cardiac imaging have supported this historical growth. Looking ahead, the market is expected to reach $10.48 billion by 2030, with an impressive CAGR of 9.9%. The forecasted rise is driven by a preference for minimally invasive cardiac interventions, demand for more durable valve implants, broadening indications for transcatheter valve use, increasing investments in structural heart disease therapies, and innovations in biological valve materials. Notable trends include the growing use of transcatheter heart valve procedures, increased demand for tissue-based valves, expansion of minimally invasive valve repair systems, advances in valve longevity, and a focus on patient-specific valve solutions.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2416&type=smp
Key Factors Fueling Demand in the Prosthetic Heart Valve Devices and Equipment Market
A major factor propelling market growth is the rising incidence of valvular heart diseases, which has increased the need for transcatheter aortic valve replacement (TAVR) procedures. TAVR is a minimally invasive surgery used to treat aortic stenosis, a condition that causes hardening of the aortic valve and restricts blood flow. This procedure replaces the damaged valve with a transcatheter valve to restore proper function. For example, in May 2023, the Centers for Disease Control and Prevention reported that over 695,000 people in the US died from heart disease, accounting for one in every five deaths. As valvular heart disease cases rise, the volume of TAVR procedures is expected to climb, increasing demand for transcatheter valves and driving market growth.
Further Drivers Supporting Market Expansion
In addition to TAVR demand, the growing aging population worldwide is increasing the incidence of valvular disorders, boosting the requirement for prosthetic heart valve devices and equipment. The expansion of cardiac surgery programs globally allows better access to advanced treatments, further supporting market growth. Advancements in cardiac imaging technologies have also enabled more accurate diagnosis and treatment planning, facilitating wider adoption of valve replacement and repair procedures.
Access The Complete Prosthetic Heart Valve Devices And Equipment Market Report:
Detailed Segmentation of the Prosthetic Heart Valve Devices and Equipment Market
This market is categorized based on product types, valve types, technology, and application areas. Product types include repair products, mitral valve repair devices, and tricuspid valve repair devices. Valve types cover transcatheter heart valves, tissue heart valves, and mechanical heart valves. Technology segments focus on biological valves and decellularized valves. Application-wise, the market serves hospitals and ambulatory surgery centers. Subcategories under repair products include transcatheter mitral valve repair (TMVR) devices and transcatheter tricuspid valve repair (TTVR) devices. Mitral valve repair devices consist of mitral valve repair systems like MitraClip, mitral valve annuloplasty devices, and edge-to-edge repair devices. Tricuspid valve repair devices include tricuspid valve annuloplasty devices and tricuspid valve repair systems.
Innovative Trends Reshaping the Prosthetic Heart Valve Devices and Equipment Industry
Leading companies in this market are focusing on developing tricuspid valve replacement systems to meet the demand for improved treatment options for tricuspid valve disease. These systems aim to enhance patient outcomes and minimize complications associated with conventional heart valve surgeries. For instance, in October 2023, Edwards Lifesciences received CE Mark approval for its EVOQUE system, the first transcatheter valve replacement therapy authorized for tricuspid regurgitation (TR). The EVOQUE valve features a nitinol self-expanding frame and bovine pericardial tissue leaflets, designed for delivery via a low-profile transfemoral 28-French system and offered in three sizes.
Competitive Landscape of the Prosthetic Heart Valve Devices and Equipment Market
The market is highly competitive with several key players, including Boston Scientific Corporation, Edwards Lifesciences, Medtronic plc, LivaNova plc, Abbott Laboratories, Jenavalve Technology Inc., Lepu Medical Technology, Cryolife Inc., Neovasc Inc., Braile Biomedica, Colibri Heart Valve, and TTK Healthcare Ltd. Additional companies active in this space are Medical Technology Est., Micro Interventional Devices Inc., Well Health Technologies, On-X Life Technologies Inc., Meril Life Sciences Pvt. Ltd., Sorin Group, Commonwealth Edison Company, Cardiac Dimensions Inc., CardioSolutions Inc., Leman Cardiovascular, MitralSolutions Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Xeltis AG, Transcatheter Technologies GmbH, Venus Medtech (Hangzhou) Inc., MValve Technologies Ltd., MVRx Inc., NaviGate Cardiac Structures Inc., Pulmonx Corporation, Tendyne Holdings Inc., ValveXchange Inc., Vascutek Ltd., XpandOrtho Inc., and Zhejiang A&F Medical Co. Ltd.
Regional Market Dominance and Growth Patterns
North America held the largest share of the global prosthetic heart valve devices and equipment market in 2025. Western Europe ranked as the second-largest region. The market report also covers other important regions such as Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East, and Africa, providing a broad perspective on global market trends and opportunities.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
